Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 10 studies | 36% ± 20% | |
epithelial cell | 5 studies | 43% ± 25% | |
squamous epithelial cell | 4 studies | 50% ± 24% | |
secretory cell | 3 studies | 38% ± 18% | |
keratinocyte | 3 studies | 31% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
esophagus | 3 studies | 45% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 40% | 56522.70 | 581 / 1445 | 88% | 132.41 | 161 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.18 | 1 / 1 |
skin | 72% | 25418.03 | 1299 / 1809 | 28% | 13.89 | 131 / 472 |
tonsil | 0% | 0 | 0 / 0 | 98% | 138.52 | 44 / 45 |
lung | 0% | 0 | 0 / 578 | 77% | 20.51 | 894 / 1155 |
pancreas | 0% | 16.31 | 1 / 328 | 74% | 7.44 | 132 / 178 |
uterus | 2% | 2086.38 | 3 / 170 | 72% | 58.70 | 329 / 459 |
bladder | 0% | 0 | 0 / 21 | 66% | 11.85 | 332 / 504 |
intestine | 1% | 28.05 | 9 / 966 | 61% | 16.19 | 319 / 527 |
stomach | 1% | 257.15 | 3 / 359 | 53% | 5.17 | 152 / 286 |
ovary | 0% | 0 | 0 / 180 | 41% | 1.75 | 177 / 430 |
thymus | 2% | 71.78 | 15 / 653 | 32% | 2.28 | 196 / 605 |
kidney | 0% | 0 | 0 / 89 | 28% | 2.29 | 252 / 901 |
prostate | 1% | 28.69 | 2 / 245 | 23% | 1.68 | 117 / 502 |
liver | 0% | 0 | 0 / 226 | 14% | 0.67 | 56 / 406 |
breast | 0% | 7.39 | 1 / 459 | 11% | 1.09 | 122 / 1118 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.21 | 1 / 29 |
adrenal gland | 0% | 0 | 0 / 258 | 2% | 0.10 | 4 / 230 |
eye | 0% | 0 | 0 / 0 | 1% | 0.28 | 1 / 80 |
adipose | 1% | 54.51 | 7 / 1204 | 0% | 0 | 0 / 0 |
brain | 0% | 0 | 0 / 2642 | 0% | 0.02 | 3 / 705 |
muscle | 0% | 24.72 | 2 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 2.98 | 1 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 11.47 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0045580 | Biological process | regulation of T cell differentiation |
GO_1902572 | Biological process | negative regulation of serine-type peptidase activity |
GO_0030855 | Biological process | epithelial cell differentiation |
GO_0007275 | Biological process | multicellular organism development |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0050777 | Biological process | negative regulation of immune response |
GO_0035315 | Biological process | hair cell differentiation |
GO_0009913 | Biological process | epidermal cell differentiation |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0002787 | Biological process | negative regulation of antibacterial peptide production |
GO_0045861 | Biological process | negative regulation of proteolysis |
GO_0030154 | Biological process | cell differentiation |
GO_0051884 | Biological process | regulation of timing of anagen |
GO_0007417 | Biological process | central nervous system development |
GO_0030155 | Biological process | regulation of cell adhesion |
GO_0005576 | Cellular component | extracellular region |
GO_0097209 | Cellular component | epidermal lamellar body |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
Gene name | SPINK5 |
Protein name | Serine protease inhibitor Kazal-type 5 (Lympho-epithelial Kazal-type-related inhibitor) (LEKTI) [Cleaved into: Hemofiltrate peptide HF6478; Hemofiltrate peptide HF7665] Serine peptidase inhibitor Kazal type 5 |
Synonyms | |
Description | FUNCTION: Serine protease inhibitor, probably important for the anti-inflammatory and/or antimicrobial protection of mucous epithelia. Contribute to the integrity and protective barrier function of the skin by regulating the activity of defense-activating and desquamation-involved proteases. Inhibits KLK5, it's major target, in a pH-dependent manner. Inhibits KLK7, KLK14 CASP14, and trypsin. . |
Accessions | E5RG22 ENST00000359874.7 [Q9NQ38-3] E7EWP9 ENST00000508733.5 E5RFU9 ENST00000256084.8 [Q9NQ38-1] ENST00000476697.7 ENST00000521206.5 Q9NQ38 ENST00000398454.5 [Q9NQ38-2] |